VENTURE DEEPTECH

Deeptech: Building the industry of tomorrow

At Audacia, we see investing in Deep Tech as more than just a financial investment. It’s about identifying pioneers of emerging technologies and helping them grow into the global leaders of tomorrow.

Deeptech is distinguished by its projects from the best research laboratories in the world, involving sometimes long technological development phases, in order to transform scientific advances into marketable products.

Investing in these companies today means becoming a shareholder in the leaders of tomorrow.

We are committed to supporting these innovations while building lasting partnerships with visionary entrepreneurs.

At the forefront of science and engineering

Deeptech, at the forefront of science and engineering, develops innovations such as quantum computing, AI, space technologies, and carbon-free energy. These projects address crucial health and energy challenges. Audacia supports these future technologies by providing financial resources and expertise to entrepreneurs in these fields.

Discover our news on this sector

An international vision

Our investment strategy has a national and international focus, ensuring that our Deeptech projects have the global impact necessary for their success. These cutting-edge innovations are inherently global in scope, and we leverage our international network to help startups develop their technologies and explore new markets. We are the first to invest in pioneering funds such as the first quantum fund, Quantonation, launched in 2018, and the VC fund dedicated to New Space, Expansion.

Commitment to social and environmental responsibility

Today’s challenges require Deeptech projects to not only innovate, but also lead the way in sustainability and social responsibility. Audacia recognizes the environmental and societal impacts of new technologies. That’s why our investment decisions are guided by a strong ESG framework, ensuring that the technologies we support contribute to a better future for all.

Discover our ESG policy in Venture Deeptech

Strategic collaborations and unique expertise

We collaborate with universities and researchers to foster synergies between investors and startups. Anchored in the Deeptech ecosystem, our team combines scientific and commercial expertise, offering personalized support to accelerate their success. More than investors, we are partners in innovation.

Meet our dedicated team

OUR 4 THESIS

The emergence of technological and industrial startups in 4 sectors

Quantum

Quantum technologies in the spotlight

Through Quantonation, venture capital funds dedicated to quantum technologies, the Audacia Group is now a decisive place for the financing of technological innovations.
Learn more

PARTICIPATIONS

34 in portfolio
0 sold

GEOGRAPHY

Worldwide market

QUANTONATION PARTICIPATIONS

New Space

GEOGRAPHY

European Market

EXPANSION PARTICIPATIONS

Energy

A fund serving resilient and sovereign European energy

A Franco-Italian venture capital fund dedicated to new nuclear power, energy storage and energy efficiency, Exergon aims to finance disruptive technologies that will accelerate the energy transition.

Exergon aims to deploy nearly 200 million euros in around thirty European startups.

Learn more

PARTICIPATIONS

7 in portfolio
0 sold

GEOGRAPHY

European Market

EXERGON'S SHARES

Healthtech

To support and transform Sorbonne University’s pool of excellence into a leader in an emerging industry, Audacia, in collaboration with Aloé Private Equity, is launching the Sorbonne Venture Fund, a seed fund dedicated to disruptive innovations in Healthtech, thus strengthening the bridge between academic excellence, cutting-edge research, and the entrepreneurial world. Sorbonne Venture aims to deploy nearly €100 million in around fifteen startups and will invest from pre-seed to Series A.

TARGET SIZE

100M€

PARTICIPATIONS

3 in portfolio
0 sold

INVESTMENT STAGE

Multi-stage priming

SORBONNE VENTURE PARTICIPATIONS

14 October 2025

EVerZom raises €10 million to accelerate the development of exosome-based biotherapies

EVerZom , a French company pioneering exosome-based therapies for regenerative medicine applications, announces a €10 million fundraising round. This round was completed with support from Capital Grand Est, the European […]

1 October 2025

Charles Beigbeder speaks at BIG 2025

Watch the full video presentation by Charles Beigbeder, General Partner of the Expansion fund, during a roundtable discussion organized by Bpifrance in the Deeptech room at BIG 2025. He was […]

24 July 2025

Austral Dx raises €2.5 million to reinvent cardiopulmonary diagnostics

Austral Dx, a deep tech startup founded in 2021, has announced that it has raised €2.5 million in funding to accelerate the development of its contactless medical device, which can […]

4 June 2025

Charles Beigbeder in Maddyness: ‘Create £1 billion class funds for European deep tech’

‘We support nearly 70 technology companies. We have invested nearly €150 million in these 70 start-ups, which have raised a total of around €800 million and created more than 2,000 […]

2 May 2025

Audacia aims to reach €1 billion in assets under management by 2025

The company, listed on Euronext Growth, managed €705 million at the end of 2024 and saw its net asset value per share increase by 8.5% year-on-year. Article available on the […]

13 April 2025

Webinar – Energy transition: Investment opportunities in decarbonisation

The Exergon fund, dedicated to decarbonisation, participated in a webinar on new investment opportunities in the energy transition. Organised in partnership with Natixis CIB and the Institut Montaigne, this webinar […]

10 February 2025

Charles Beigbeder on CNEWS: Advocacy for innovative financing and the growth of disruptive technologies

Charles Beigbeder, president of the Audacia investment fund, was recently a guest on the show “Patrons en questions” on CNEWS. During this interview, he shared his vision on business financing […]

27 December 2024

Expansion Ventures completes first round of funding of 137 million euros

Audacia is proud to announce the first round of funding of Expansion SLP, a pan-European venture capital fund dedicated to Sustainable Aerospace and Defence technologies. This milestone demonstrates strong investor […]

10 December 2024

Biomemory Raises €17 Million in Series A to Revolutionize Data Storage Using Molecular Technology

Biomemory, a pioneer in DNA data storage, today announced a €17 million Series A funding round. The funding round was led by Credit Mutuel Innovation, with the historic participation of […]

4 November 2024

Expansion awarded Tibi 2 label

Press release

OUR EXPERTISE

Discover our other areas of expertise

Private Equity

Real Estate